These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28065323)

  • 61. Biomimetic nano drug delivery carriers for treating cardiovascular diseases.
    Zinger A; Cooke JP; Taraballi F
    Nanomedicine; 2021 Apr; 33():102360. PubMed ID: 33476763
    [No Abstract]   [Full Text] [Related]  

  • 62. A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of theranostic agents. [Corrected].
    Wang H; Agarwal P; Zhao S; Yu J; Lu X; He X
    Nat Commun; 2015 Dec; 6():10081. PubMed ID: 26621191
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Polyester micelles for drug delivery and cancer theranostics: Current achievements, progresses and future perspectives.
    Yi Y; Lin G; Chen S; Liu J; Zhang H; Mi P
    Mater Sci Eng C Mater Biol Appl; 2018 Feb; 83():218-232. PubMed ID: 29208282
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Aggregation Induced Emission Mediated Controlled Release by Using a Built-In Functionalized Nanocluster with Theranostic Features.
    Zhou Z; Zhang CC; Zheng Y; Wang Q
    J Med Chem; 2016 Jan; 59(1):410-8. PubMed ID: 26689502
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Development of biodegradable polyesters with various microstructures for highly controlled release of epirubicin and cyclophosphamide.
    Żółtowska K; Piotrowska U; Oledzka E; Luchowska U; Sobczak M; Bocho-Janiszewska A
    Eur J Pharm Sci; 2017 Jan; 96():440-448. PubMed ID: 27742595
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A Theranostic Two-Tone Luminescent PhotoCORM Derived from Re(I) and (2-Pyridyl)-benzothiazole: Trackable CO Delivery to Malignant Cells.
    Carrington SJ; Chakraborty I; Bernard JM; Mascharak PK
    Inorg Chem; 2016 Aug; 55(16):7852-8. PubMed ID: 27082125
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Targeting and Regulating of an Oncogene via Nanovector Delivery of MicroRNA using Patient-Derived Xenografts.
    Sun S; Wang Y; Zhou R; Deng Z; Han Y; Han X; Tao W; Yang Z; Shi C; Hong D; Li J; Shi D; Zhang Z
    Theranostics; 2017; 7(3):677-693. PubMed ID: 28255359
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An optimized gastroretentive nanosystem for the delivery of levodopa.
    Ngwuluka NC; Choonara YE; Kumar P; du Toit LC; Modi G; Pillay V
    Int J Pharm; 2015 Oct; 494(1):49-65. PubMed ID: 26260231
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Preparation of poly(-isopropylacrylamide) hollow beads as reservoir drug delivery systems.
    Khorram M; Vasheghani-Farahani E; Dinarvand R
    J Control Release; 2006 Nov; 116(2):e31-3. PubMed ID: 17718955
    [No Abstract]   [Full Text] [Related]  

  • 70. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
    Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Advances in the synthesis and application of nanoparticles for drug delivery.
    Park W; Na K
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(4):494-508. PubMed ID: 25583540
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Frontiers in radionuclide imaging and therapy, a chemical journey from naturally radioactive elements to targeted theranostic agents.
    Casini A; Orvig C; Correia JDG
    Dalton Trans; 2017 Oct; 46(42):14433-14434. PubMed ID: 29057999
    [No Abstract]   [Full Text] [Related]  

  • 73. Multi-Target Drugs Against Metabolic Disorders.
    Scotti L; Scotti MT
    Endocr Metab Immune Disord Drug Targets; 2019; 19(4):389-390. PubMed ID: 31274061
    [No Abstract]   [Full Text] [Related]  

  • 74. Editorial: controlled release and drug delivery in diseases.
    Tutar Y
    Protein Pept Lett; 2014; 21(11):1085-6. PubMed ID: 25315373
    [No Abstract]   [Full Text] [Related]  

  • 75. Cell-based drug delivery devices using phagocytosis-resistant backpacks.
    Doshi N; Swiston AJ; Gilbert JB; Alcaraz ML; Cohen RE; Rubner MF; Mitragotri S
    Adv Mater; 2011 Mar; 23(12):H105-9. PubMed ID: 21365691
    [No Abstract]   [Full Text] [Related]  

  • 76. Editorial (Thematic Issue: Targeted Anti-Cancer Drug Delivery).
    Liang F; Chen B; Zhang C
    Curr Cancer Drug Targets; 2016; 16(6):467-8. PubMed ID: 27452678
    [No Abstract]   [Full Text] [Related]  

  • 77. Drug Release: Proper Control to Help Clinical Application.
    Ashammakhi N
    J Craniofac Surg; 2018 Jan; 29(1):124-125. PubMed ID: 29135731
    [No Abstract]   [Full Text] [Related]  

  • 78. Editorial.
    Doschak MR; Allen C; Ho E
    Drug Deliv Transl Res; 2017 Aug; 7(4):465. PubMed ID: 28707265
    [No Abstract]   [Full Text] [Related]  

  • 79. Editorial.
    Mohd Amin MCI; Kiew LV; Boyd B
    Drug Deliv Transl Res; 2019 Apr; 9(2):417. PubMed ID: 29748831
    [No Abstract]   [Full Text] [Related]  

  • 80. The Effect of Repeat Administration of Lipoplexes on Gene Delivery, Biodistribution, and Cytokine Response in Immunocompetent Tumor-Bearing Mice.
    Betker JL; Anchordoquy TJ
    J Pharm Sci; 2022 Jul; 111(7):1926-1936. PubMed ID: 34929156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.